Compare GNT & PRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GNT | PRE |
|---|---|---|
| Founded | 2011 | 2014 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Biotechnology: Laboratory Analytical Instruments |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 126.2M | 131.3M |
| IPO Year | N/A | N/A |
| Metric | GNT | PRE |
|---|---|---|
| Price | $7.49 | $15.70 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $32.00 |
| AVG Volume (30 Days) | 40.9K | ★ 135.8K |
| Earning Date | 01-01-0001 | 11-10-2025 |
| Dividend Yield | ★ 6.61% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.95 | N/A |
| Revenue | N/A | ★ $77,079,000.00 |
| Revenue This Year | N/A | $219.28 |
| Revenue Next Year | N/A | $124.38 |
| P/E Ratio | $5.36 | ★ N/A |
| Revenue Growth | N/A | ★ 201.54 |
| 52 Week Low | $4.59 | $3.10 |
| 52 Week High | $5.40 | $18.48 |
| Indicator | GNT | PRE |
|---|---|---|
| Relative Strength Index (RSI) | 49.20 | 52.15 |
| Support Level | $7.52 | $16.17 |
| Resistance Level | $8.00 | $18.48 |
| Average True Range (ATR) | 0.17 | 1.27 |
| MACD | -0.04 | -0.09 |
| Stochastic Oscillator | 11.94 | 39.91 |
GAMCO Natural Resources, Gold & Income Trust is a non-diversified closed-end management investment company. The company's primary investment objective is to provide a high level of current income from interest, dividends, and options premiums with its secondary objective being capital appreciation. Under normal market conditions, the company invests majority of its assets in securities of companies principally engaged in the natural resources and gold industries, and also engages in writing covered call options on the underlying equity securities. Its portfolio consists of securities from different sectors such as metals and mining, energy and energy services, specialty chemicals, agriculture, healthcare, machinery, food and beverage, and others.
Prenetics Global Ltd is a health sciences company dedicated to consumer and clinical health. Its consumer initiative is led by IM8, a new health and wellness brand, and Europa, a U.S. sports distribution company. The clinical division is led by Insighta, focused on multi-cancer early detection technologies. This is followed by ACT Genomics, which has achieved FDA clearance for genomic profiling of solid tumors, and CircleDNA, which uses NGS to offer DNA tests. Each Prenetics unit impacts health by 'enhancing life through science'.